Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes

Leukemia Research

Volumn 20, Issue 11-12, 1996, Pages 891-900

  Shetty, Vilasini ^a   Mundle, Suneel ^a   Alvi, Sairah ^a   Showel, Margaret ^a   Broady Robinson, LaTanya ^a   Dar, Saleem ^a   Borok, Raphael ^a   Showel, John ^a   Gregory, Stephanie ^a   Rifkin, Shelby ^b   Gezer, Sefer ^a   Parcharidou, Agapi ^a   Venugopal, Parameswaran ^a   Shah, Rohit ^c   Hernandez, Beatrice ^d   Klein, Mary ^e   Alston, Devena ^d   Robin, Erwin ^f   Dominquez, Carlos ^g   Raza, Azra ^a  

^a RUSH CANCER INSTITUTE   (United States)

^b NORTHWEST COMMUNITY HOSPITAL   (United States)

^c Lake Forest Hospital   (United States)

^d LaPorte Cancer Treatment Center   (United States)

^e St Anthony Hospital   (United States)

^f Ingalls Memorial Hospital   (United States)

^g Miami Beach FL   (United States)

Author keywords

Apoptosis and macrophages; Granulocyte macrophage colony stimulating factor (GM CSF); Myelodysplastic syndrome; Transforming growth factor beta (TGF ); Tumor necrosis factor alpha (TNF )

Indexed keywords

BROXURIDINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IDOXURIDINE; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BIRTH RATE; BONE MARROW BIOPSY; BONE MARROW CELL; CELL DEATH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; ERYTHROID CELL; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; MALE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; PARENCHYMA; PRIORITY JOURNAL; STROMA CELL;

APOPTOSIS; BONE MARROW; CELL DIVISION; CELL LINEAGE; CONNECTIVE TISSUE; DNA FRAGMENTATION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MACROPHAGES; MALE; MYELODYSPLASTIC SYNDROMES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030294026     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00008-2     Document Type: Article

References (32)

1. 1. Koeffler P. (1986) Myelodysplastic syndromes (preleukemia). Semin. Hematol. 23, 284.
2. 2. Mufti G. J. & Galton D. A. G. (1986) Myelodysplastic syndromes: natural history and features of prognostic importance. Clin. Haematol. 15, 953.
3. 3. Willemze R., Fibbe W. E., Falkenberg J. H. F., Kluin-Nelemans J. C., Kluin P. M. & Landequist J. E. (1993) Biology and treatment of myelodysplastic syndromes -development in the past decade (Review). Ann. Hematol. 66, 107.
4. 4. Tricot G., Boogaerts M. A. & Wolf-Peeters C. D. (1985) The myelodysplastic syndromes: different evolution pattern based on sequential morphological and cytogenetic investigations. Br. J. Haematol. 59, 659.
5. 5. Clark D. & Lampert I. (1990) Apoptosis is a common histopathological finding in myelodysplasia: the correlate of ineffective haematopoiesis. Leuk. Lymphoma 2, 415.
6. 6. Mundle S., Iftikhar A., Shetty V., Alvi S., Dameron S., Gregory S., Marcus B., Khan S. & Raza A. (1994) In situ end labeling of DNA to detect apoptotic cell death in a variety of human tumors. Cell Death Different. 1, 117.
7. 7. Raza A., Mundle S., Iftikhar A., Gregory S., Marcus B., Khan Z., Alvi S., Shetty V., Dameron S., Wright V., Adler S., Loew J., Shott S., Ali N. & Preisler H. (1995) Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveal extensive apoptosis as the probable basis for ineffective hematopoiesis. Am. J. Hematol. 48, 143.
8. 8. Kristen M. (1987) Different activities of tumor necrosis factor on murine and human cell lines. Diss. Abstr. Int. (Sci.) 48, 1601.
9. 9. Munter R., DiPersio J. & Koeffler H. P. (1987) Tumor necrosis factor: receptors on hematopoietic cells. Blood 70, 1730.
10. 10. Murase T., Hotta T., Saito H. & Ohno R. (1987) Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells. Blood 69, 467.
11. 11. Broxmeyer H., Williams D., Lu L., Copper S., Anderson S., Beyer G., Hoffman R. & Rubin B. (1986) The suppressive influences of human tumor necrosis factor on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon γ. J. Immunol. 136, 4487.
12. 12. Libby P., Ordaros J., Anger K., Alson K., Bironyi L. & Dinarello C. (1986) Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am. J. Pathol. 124, 17.
13. 13. Zucali J., Broxmeyer H., Gross M. & Dinarello C. (1988) Recombinant human tumor necrosis factor α and β stimulate fibroblasts to produce hematopoietic growth factors in vitro. J. Immunol. 140, 840.
14. 14. Aggarwal B., Khor W. & Hass P. (1985) Human tumor necrosis factor: production, purification and characterization. J. biol. Chem. 260, 2345.
15. 15. Sallerfors B. (1994) Endogenous production and peripheral levels of granulocyte-macrophage (GM-) and granulocyte (G-) colony stimulating factors. Leuk. Lymphoma 13, 235.
16. 16. Harmenberg J., Hoglund M. & Hellstrom-Lindberg E. (1994) G-and GM-CSF in oncology and oncological hematology. Eur. J. Haematol. Suppl. 55, 1.
17. 17. Cebon J. S. & Leischke G. J. (1994) Granulocyte-macrophage colony-stimulating factor for cancer treatment. Oncology 51, 177.
18. 18. Sporn M., Roberts A., Wakefield L. & Crombrugghe B. de (1987) Some recent advances in the chemistry of transforming growth factor-beta. J. cell. Biol. 105, 1039.
19. 19. Moses H., Coffey R. Jr., Leof E. & Keski-Oja J. (1987) Transforming growth factor beta regulation of cell proliferation. J. Cell Physiol. 5, 1.
20. 20. Goustin A., Leof E., Shipley G. & Moses H. (1986) Perspective in cancer research: growth factors and cancer. Cancer Res. 46, 1015.
21. 21. Bennett J., Catovsky D., Flandrin D., Galton D., Gralnick H. & Sultan C. (1982) Proposal for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51, 189.
22. 22. Raza A., Yousuf N., Bokhari S. A. J., Sheikh Y., Akhtar S., Chugtai S., Umerani A., Mehdi A., Miller M., Masterson M. & Lampkin B. (1992) In situ cell kinetics in bone marrow biopsies following sequential infusions of IUdR/ BrdU in patients with hematopoietic malignancies. Anti Cancer Res. 12, 403.
23. 23. Raza A., Gezer S., Mundle S., Xue-Zhi G., Alvi S., Borok R., Shelby R., Iftikhar A., Shetty V., Parcharidou A., Loew J., Marcus B., Khan Z., Chaney C., Showel J., Gregory S. & Preisler H. (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86, 268.
24. 24. Stone R. M., Neuberg D., Soiffer R., Takvoian T., Whelan M., Rabinowe S. N., Aster J. C., Leavitt P., Manch P., Freedman A. S. & Nadler L. M. (1994) Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J. Clin. Oncol. 12, 2535.
25. 25. Mulder N. H., Mulder P. O., Sleijfer D. T., Willemse P. H., Van der Ploeg E., Dolsma W. V. & Vries E. G. de (1993) Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer. Eur. J. Cancer 29A, 668.
26. 26. Greenberg P. L. (1991) Treatment of myelodysplastic syndromes. Blood Rev. 5, 42.
27. 27. Raza A., Preisler H. D., Alvi S., Venugopal P., Gezer S., Borok R., Mundle S., Shetty V., Chopra H., Hines C., Jassak P., Gregory S. A., Robin E., Kawauchi R., Rifkin S., Alston D., Hernandez B. & Shah R. (1996) The dual role of tumor necrosis factor alpha in the pathogenesis of 89 patients with myelodysplastic syndromes. Proc. Am. Ass. Canc. Res. 37, Abst 1306.
28. 28. Raza A., Alvi S., Venugopal P., Gezer S., Borok R., Mundle S., Shetty V., Chopra H., Hines C., Jassak P., Gregory S. A., Robin E., Rifkin S., Alston D., Hernandez B. & Shah R. (1996) Effects of Pentoxifylline/Ciprofloxacin on cytokines, apoptosis and cell cycle in patients with myelodysplastic syndromes. Proc. Am. Soc. Clin. Oncol. 15, Abst 1404.
29. 29. Clark E., Rice G. C., Weaks R. S., Jenkins N., Nelson R., Bianco J. A. & Singler J. W. (1996) Lisophylline inhibits TGF-β release and enhances trilineage recovery after 5-fluorouracil treatment in mice. Cancer Res. 56, 105.
30. 30. Biswas D. K., Dezube B. J., Aulers C. M. & Pardee A. B. (1993) Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-KB action. J. Acq. Imm. Def. Syndr. 6, 778.
31. 31. Sampaio E. P., Kaplan G., Miranda A., Nery J. A., Miguel C. P., Viana S. M. & Sarno E. N. (1993) The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J. Infect. Dis. 168, 408.
32. 32. Litzow M. R. & Kyle R. A. (1989) Multiple responses of aplastic anemia to low-dose cyclosporin therapy despite development of a myelodysplastic syndrome. Am J. Hematol. 32, 226.